
    
      The purpose of this prospective, double blind parallel group randomized study is to compare
      the effects of ferric carboxymaltose vs. placebo on skeletal muscle mitochondrial oxidative
      capacity, submaximal exercise tolerance, and health-related quality of life in non-anemic
      Heart Failure (HF) patients with functional iron deficiency.
    
  